Khaled H. Hatem

The regulatory landscape for clinical metagenomics-based diagnostics in Europe: a critical review.

Metagenomic next-generation sequencing (mNGS) enables broad, untargeted pathogen detection and is increasingly used in the diagnosis of central nervous system infections, infections in immunocompromised or post-transplant patients, ICU patients, and sepsis. This growing clinical role makes the regulatory landscape surr...